GDF15 and obesity disorder: It has already been confirmed that obesity induces lower levels of NT-proBNP; this aspect, in conjunction with the significant percentage of 35% obese patients in our study, provides a reasonable explanation for a lower prognostic value compared to GDF-15, which is not influenced by such confounding factors [24,62].